stockrow
Saturday 31 October 2026
Export OHI’s income statement to Excel — free account
Omega Healthcare Investors, Inc.
OHI Real Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.
46.98
0.14
+0.30%
Follow OHI
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
16.82 | 54.86 | 25.11 | 26.47 | 51.15 | 16.72 | 15.53 | 31.16 | 24.11 | 22.74 |
Piotroski F-Score |
6 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 7 | 6 |
P/S ratio |
6.80 | 5.97 | 7.98 | 9.73 | 9.27 | 6.60 | 7.52 | 7.81 | 9.29 | 10.87 |
P/FCF ratio |
0.00 | 51.26 | 31.29 | 0.00 | 16.66 | 0.00 | 19.93 | 27.20 | 41.74 | 159.52 |
P/Operating CF |
36.57 | 36.01 | 46.65 | 61.07 | 41.91 | 44.79 | 42.98 | 44.97 | 42.67 | 56.07 |
P/B ratio |
1.45 | 1.40 | 1.87 | 2.08 | 2.05 | 1.71 | 1.74 | 1.97 | 2.07 | 2.38 |
Price to Tangible BV |
1.72 | 1.67 | 2.26 | 2.45 | 2.44 | 2.03 | 2.09 | 2.38 | 2.39 | 2.70 |
EV/Sales |
11.53 | 10.90 | 13.12 | 15.22 | 14.87 | 11.52 | 13.20 | 12.68 | 13.37 | 11.02 |
EV/EBITDA |
12.60 | 16.21 | 15.38 | 17.64 | 18.74 | 13.66 | 17.78 | 16.60 | 14.94 | 12.57 |
EV/Operating CF |
16.63 | 17.13 | 23.17 | 25.54 | 18.74 | 16.95 | 18.53 | 19.49 | 18.76 | 14.93 |
EV/FCF |
(23.37) | 93.56 | 51.42 | (848.56) | 26.74 | (362.68) | 34.98 | 44.15 | 60.07 | 161.84 |
Quick Ratio |
0.96 | 1.27 | 0.17 | 0.19 | 0.63 | 0.58 | 1.70 | 2.54 | 2.72 | 1.12 |
Current Ratio |
2.74 | 3.55 | 2.78 | 2.67 | 3.79 | 4.84 | 5.01 | 6.76 | 7.07 | 5.04 |
Net Debt/EBITDA |
5.17 | 7.33 | 6.02 | 6.37 | 7.06 | 5.84 | 7.65 | 6.37 | 4.56 | 4.03 |
Debt/Assets |
48.80% | 52.11% | 52.85% | 52.43% | 54.43% | 54.51% | 56.21% | 55.58% | 48.89% | 42.35% |
Debt/Equity |
1.04 | 1.18 | 1.21 | 1.18 | 1.28 | 1.28 | 1.39 | 1.35 | 1.02 | 0.78 |
Asset Turnover |
0.11 | 0.10 | 0.10 | 0.10 | 0.09 | 0.11 | 0.09 | 0.10 | 0.11 | 0.12 |
Operating CF/Net income |
1.71 | 5.76 | 1.77 | 1.62 | 4.45 | 1.73 | 1.43 | 2.48 | 1.79 | 1.49 |
Capex/Depreciation |
(4.04) | (1.60) | (0.98) | (1.87) | (0.65) | (2.01) | (0.87) | (1.03) | (1.63) | (2.44) |
Interest Coverage |
3.19 | 1.43 | 2.35 | 2.38 | 1.70 | 2.22 | 1.34 | 1.66 | 2.82 | 3.33 |
| 8.82% | 2.48% | 7.36% | 8.42% | 3.81% | 10.23% | 11.09% | 6.59% | 9.85% | 11.63% | |
| 4.33% | 1.13% | 3.24% | 3.71% | 1.65% | 4.36% | 4.61% | 2.69% | 4.40% | 5.93% | |
ROIC |
4.13% | 2.36% | 3.56% | 3.28% | 2.63% | 3.48% | 2.22% | 2.92% | 4.32% | 4.65% |
Return on Tangible Assets |
5.27% | 1.43% | 4.22% | 4.42% | 2.13% | 5.27% | 5.63% | 3.30% | 5.02% | 7.28% |
Average Days of Receivables |
97.26 | 112.24 | 14.00 | 10.66 | 4.26 | 46.52 | 97.05 | 110.49 | 119.73 | 104.29 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
5.09% | 5.25% | 7.20% | 6.23% | 6.71% | 6.08% | 7.90% | 8.58% | 8.37% | 8.75% |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 |
Share Based Compensation of Revenue |
1.53% | 1.67% | 1.81% | 1.65% | 2.11% | 2.01% | 3.11% | 3.69% | 3.49% | 3.71% |
Graham Net Nets |
(0.61) | (0.71) | (0.58) | (0.51) | (0.53) | (0.60) | (0.61) | (0.46) | (0.29) | (0.20) |
Graham Number |
30.64 | 14.87 | 24.33 | 27.05 | 16.83 | 26.28 | 25.53 | 18.67 | 25.44 | 28.61 |
Earnings Yield |
5.95% | 1.82% | 3.98% | 3.78% | 1.95% | 5.98% | 6.44% | 3.21% | 4.15% | 4.40% |
Free Cash Flow Yield |
(7.25%) | 1.95% | 3.20% | (0.18%) | 6.00% | (0.48%) | 5.02% | 3.68% | 2.40% | 0.63% |
Revenue per Share |
4.70 | 4.59 | 4.40 | 4.35 | 3.92 | 4.49 | 3.72 | 3.95 | 4.07 | 4.08 |
Operating CF per Share |
3.26 | 2.92 | 2.49 | 2.59 | 3.11 | 3.05 | 2.65 | 2.57 | 2.90 | 3.01 |
Capex per Share |
(5.58) | (2.39) | (1.37) | (2.67) | (0.93) | (3.19) | (1.25) | (1.43) | (2.00) | (2.73) |
Free Cash Flow per Share |
(2.32) | 0.54 | 1.12 | (0.08) | 2.18 | (0.14) | 1.40 | 1.13 | 0.91 | 0.28 |
Cash per Share |
0.56 | 0.49 | 0.06 | 0.16 | 0.74 | 0.10 | 1.27 | 1.85 | 2.13 | 0.19 |
Shareholders Equity per Share |
21.96 | 19.66 | 18.80 | 20.32 | 17.72 | 17.34 | 16.10 | 15.64 | 18.33 | 18.65 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21.96 | 19.66 | 18.80 | 20.32 | 17.72 | 17.34 | 16.10 | 15.64 | 18.33 | 18.65 |
Free Cash Flow |
(444.43) | 105.81 | 224.99 | (16.66) | 496.41 | (33.75) | 331.39 | 272.78 | 234.07 | 81.06 |
Working Capital |
626.14 | 752.23 | 484.18 | 522.03 | 782.46 | 1,063.92 | 1,261.84 | 1,656.60 | 1,993.73 | 1,423.01 |
Capital Expenditures |
(1,069.20) | (472.11) | (274.38) | (570.41) | (211.85) | (755.88) | (294.34) | (344.96) | (515.36) | (797.49) |
Net Current Asset Value |
(3,750.62) | (3,837.67) | (4,070.04) | (4,625.46) | (4,397.56) | (4,189.61) | (4,025.00) | (3,410.72) | (2,845.13) | (2,833.00) |
EV/EBIT |
18.55 | 31.41 | 24.47 | 28.51 | 34.85 | 23.52 | 37.18 | 30.74 | 22.52 | 18.29 |
Capex to Sales |
1.19 | 0.52 | 0.31 | 0.61 | 0.24 | 0.71 | 0.34 | 0.36 | 0.49 | 0.67 |
Price to Operating Income |
10.94 | 17.21 | 14.89 | 18.22 | 21.72 | 13.47 | 21.18 | 18.94 | 15.65 | 18.03 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
Cash ROIC |
(5.12%) | 1.24% | 2.71% | (0.18%) | 5.30% | (0.36%) | 3.53% | 2.94% | 2.31% | 0.83% |
Accounts Receivable Turnover |
4.06 | 3.50 | 5.63 | 30.48 | 47.56 | 14.57 | 4.76 | 3.65 | 3.33 | 3.48 |
Average Receivables |
221.95 | 259.68 | 156.58 | 30.47 | 18.77 | 72.93 | 184.48 | 260.51 | 316.19 | 342.47 |
Average Assets |
8,469.60 | 8,861.28 | 8,682.09 | 9,193.50 | 9,646.79 | 9,567.96 | 9,521.82 | 9,261.28 | 9,507.65 | 9,973.48 |
Average Common Equity |
4,156.43 | 4,050.12 | 3,826.37 | 4,050.54 | 4,186.60 | 4,072.42 | 3,955.75 | 3,782.79 | 4,246.57 | 5,085.67 |
Columns are period end dates · fundamentals updated 25 Oct 2026